{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:25:32Z","timestamp":1794900332473,"version":"4.9.1"},"reference-count":224,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Polycystic ovary syndrome (PCOS) is a common endocrine disorder characterized by chronic ovulation dysfunction and overabundance of androgens; it affects 6\u201320% of women of reproductive age. PCOS involves various pathophysiological factors, and affected women usually have significant insulin resistance (IR), which is a major cause of PCOS. IR and compensatory hyperinsulinaemia have differing pathogeneses in various tissues, and IR varies among different PCOS phenotypes. Genetic and epigenetic changes, hyperandrogenaemia, and obesity aggravate IR. Insulin sensitization drugs are a new treatment modality for PCOS. We searched PubMed,\u00a0Google Scholar, Elsevier, and UpToDate databases\u00a0in this review, and focused\u00a0on the pathogenesis of IR in women with PCOS and the pathophysiology of IR in various tissues. In addition, the review\u00a0provides a comprehensive overview of the current progress in the efficacy of insulin sensitization therapy in the management of PCOS, providing the latest evidence for the clinical treatment of women with PCOS and IR.<\/jats:p>","DOI":"10.1186\/s13048-022-01091-0","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T03:03:33Z","timestamp":1673406213000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":415,"title":["Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment"],"prefix":"10.1186","volume":"16","author":[{"given":"Han","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhao","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"1091_CR1","unstructured":"Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Boston. 1992;77\u201384."},{"issue":"1","key":"1091_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop groxup","year":"2004","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop groxup. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum\u00a0Reprod (Oxford, England). 2004;19(1):41\u20137.","journal-title":"Hum\u00a0Reprod (Oxford, England)"},{"issue":"11","key":"1091_CR3","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale H, Futterweit W, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237\u201345.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1091_CR4","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz B. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum\u00a0Reprod (Oxford, England). 2016;31(12):2841\u201355.","journal-title":"Hum\u00a0Reprod (Oxford, England)"},{"issue":"6","key":"1091_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003132","volume":"17","author":"M Dapas","year":"2020","unstructured":"Dapas M, Lin F, Nadkarni G, Sisk R, Legro R, Urbanek M, et al. Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis. PLoS Med. 2020;17(6): e1003132.","journal-title":"PLoS Med"},{"issue":"3","key":"1091_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.fertnstert.2018.04.024","volume":"110","author":"B Yilmaz","year":"2018","unstructured":"Yilmaz B, Vellanki P, Ata B, Yildiz B. Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2018;110(3):523-33.e14.","journal-title":"Fertil Steril"},{"key":"1091_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.reprotox.2022.04.010","volume":"111","author":"Y Liu","year":"2022","unstructured":"Liu Y, Qin Y, Wu B, Peng H, Li M, Luo H, et al. DNA methylation in polycystic ovary syndrome: emerging evidence and challenges. Reprod\u00a0Toxicol (Elmsford, NY). 2022;111:11\u20139.","journal-title":"Reprod\u00a0Toxicol (Elmsford, NY)"},{"issue":"3","key":"1091_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/10937404.2018.1496214","volume":"21","author":"E Merlo","year":"2018","unstructured":"Merlo E, Silva I, Cardoso R, Graceli J. The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review. J Toxicol Environ Health Part B. 2018;21(3):181\u2013206.","journal-title":"J Toxicol Environ Health Part B"},{"key":"1091_CR9","doi-asserted-by":"crossref","unstructured":"Sulaiman M, Al-Farsi Y, Al-Khaduri M, Saleh J, Waly M. Polycystic ovarian syndrome is linked to increased oxidative stress in Omani women. Int J Women\u2019s Health. 2018;10:763\u201371.","DOI":"10.2147\/IJWH.S166461"},{"issue":"8","key":"1091_CR10","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/ijms23084110","volume":"23","author":"D Armanini","year":"2022","unstructured":"Armanini D, Boscaro M, Bordin L, Sabbadin C. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism. Int J Mol Sci. 2022;23(8):4110.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1091_CR11","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1530\/JME-21-0177","volume":"68","author":"M Malamouli","year":"2022","unstructured":"Malamouli M, Levinger I, McAinch A, Trewin A, Rodgers R, Moreno-Asso A. The mitochondrial profile in women with polycystic ovary syndrome: impact of exercise. J Mol Endocrinol. 2022;68(3):R11\u201323.","journal-title":"J Mol Endocrinol"},{"issue":"4","key":"1091_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.tjog.2019.05.003","volume":"58","author":"Q Liu","year":"2019","unstructured":"Liu Q, Xie Y, Qu L, Zhang M, Mo Z. Dyslipidemia involvement in the development of polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2019;58(4):447\u201353.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1091_CR13","doi-asserted-by":"crossref","unstructured":"Sadeghi H, Adeli I, Calina D, Docea A, Mousavi T, Daniali M, et al. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci. 2022;23(2):583.","DOI":"10.3390\/ijms23020583"},{"issue":"11","key":"1091_CR14","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/humrep\/dew243","volume":"31","author":"S Cassar","year":"2016","unstructured":"Cassar S, Misso M, Hopkins W, Shaw C, Teede H, Stepto N. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod (Oxford, England). 2016;31(11):2619\u201331.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"12","key":"1091_CR15","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/humrep\/dex308","volume":"32","author":"T Flavia","year":"2017","unstructured":"Flavia T, Enzo B, Paolo M. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes. Hum Reprod. 2017;32(12):2515\u201321.","journal-title":"Hum Reprod"},{"key":"1091_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1210\/jc.2018-01143","volume":"104","author":"F Gonz\u00e1lez","year":"2019","unstructured":"Gonz\u00e1lez F, Considine RV, Abdelhadi OA, Acton AJ. saturated fat ingestion promotes lipopolysaccharide- mediated inflammation and insulin resistance in polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104:934\u201346.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1091_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.fertnstert.2018.09.013","volume":"111","author":"S Zhu","year":"2019","unstructured":"Zhu S, Zhang B, Jiang X, Li Z, Chen ZJ. Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2019;111(1):168\u201377.","journal-title":"Fertil Steril"},{"key":"1091_CR18","first-page":"9","volume":"9","author":"T Flavia","year":"2021","unstructured":"Flavia T, Michela V, Matteo M, Giulia F, Sabrina G, Tom F, et al. Insulin-mediated substrate use in women with different phenotypes of PCOS: the Role of Androgens. J Clin Endocrinol Metab. 2021;9:9.","journal-title":"J Clin Endocrinol Metab"},{"key":"1091_CR19","doi-asserted-by":"crossref","unstructured":"Hoeger KM, Dokras A, Piltonen T. Update on PCOS: Consequences, Challenges and Guiding Treatment. Journal of Clinical Endocrinology & Metabolism. 2020.","DOI":"10.1210\/clinem\/dgaa839"},{"issue":"4","key":"1091_CR20","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.1210\/jc.2012-3908","volume":"98","author":"P Moghetti","year":"2013","unstructured":"Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman J-M, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(4):E628\u201337.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1091_CR21","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/humrep\/dey087","volume":"33","author":"GA Bell","year":"2018","unstructured":"Bell GA, Sundaram R, Mumford SL, et al. Maternal polycystic ovarian syndrome and early offspring development. Hum Reprod. 2018;33(7):1307\u201315.","journal-title":"Hum Reprod"},{"key":"1091_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.853473","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Guo J, Zhang Q, Zhang C. Insulin resistance is a risk factor for early miscarriage and macrosomia in patients with polycystic ovary syndrome from the first embryo transfer cycle: a retrospective cohort study. Front Endocrinol. 2022;13: 853473.","journal-title":"Front Endocrinol"},{"key":"1091_CR23","first-page":"10","volume":"10","author":"RK Hass","year":"2017","unstructured":"Hass RK, Dorte G, Mads N, Bo A, Marianne A. Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;10:10.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1091_CR24","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","volume":"26","author":"V Wekker","year":"2020","unstructured":"Wekker V, van Dammen L, Koning A, Heida K, Painter R, Limpens J, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(6):942\u201360.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1091_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.fertnstert.2018.03.009","volume":"110","author":"E Greenwood","year":"2018","unstructured":"Greenwood E, Pasch L, Cedars M, Legro R, Eisenberg E, Huddleston H. Insulin resistance is associated with depression risk in polycystic ovary syndrome. Fertil Steril. 2018;110(1):27\u201334.","journal-title":"Fertil Steril"},{"issue":"5","key":"1091_CR26","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.fertnstert.2007.05.026","volume":"89","author":"E Lee","year":"2008","unstructured":"Lee E, Oh B, Lee J, Kimm K, Lee S, Baek K. A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome. Fertil Steril. 2008;89(5):1213\u201320.","journal-title":"Fertil Steril"},{"issue":"5","key":"1091_CR27","first-page":"2027","volume":"86","author":"S Colilla","year":"2001","unstructured":"Colilla S, Cox NJ, Ehrmann DA. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives 1. J Clin Endocrinol Metab. 2001;86(5):2027\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1091_CR28","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1210\/jc.2008-0369","volume":"93","author":"S Franks","year":"2008","unstructured":"Franks S, Webber L, Goh M, Valentine A, White D, Conway G, et al. Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries. J Clin Endocrinol Metab. 2008;93(9):3396\u2013402.","journal-title":"J Clin Endocrinol Metab"},{"key":"1091_CR29","doi-asserted-by":"crossref","unstructured":"Sir-Petermann T, Codner E, P\u00e9rez V, Echibur\u00fa B, Maliqueo M, Ladr\u00f3n de Guevara A, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.\u00a0J\u00a0Clin\u00a0Endocr. 2009;94(6):1923\u201330.","DOI":"10.1210\/jc.2008-2836"},{"key":"1091_CR30","first-page":"9240569","volume":"2022","author":"Y Xu","year":"2022","unstructured":"Xu Y, Qiao J. Association of insulin resistance and elevated androgen levels with Polycystic Ovarian Syndrome (PCOS): a review of literature. J\u00a0Healthc\u00a0Eng. 2022;2022:9240569.","journal-title":"J\u00a0Healthc\u00a0Eng"},{"issue":"3","key":"1091_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tem.2014.12.004","volume":"26","author":"J McAllister","year":"2015","unstructured":"McAllister J, Legro R, Modi B, Strauss J. Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol Metab. 2015;26(3):118\u201324.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1091_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.fertnstert.2016.04.040","volume":"106","author":"M Jones","year":"2016","unstructured":"Jones M, Goodarzi M. Genetic determinants of polycystic ovary syndrome: progress and future directions. Fertil Steril. 2016;106(1):25\u201332.","journal-title":"Fertil Steril"},{"issue":"9","key":"1091_CR33","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.2384","volume":"44","author":"Y Shi","year":"2012","unstructured":"Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44(9):1020\u20135.","journal-title":"Nat Genet"},{"key":"1091_CR34","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ijbiomac.2019.10.235","volume":"144","author":"J Dakshinamoorthy","year":"2020","unstructured":"Dakshinamoorthy J, Jain P, Ramamoorthy T, Ayyappan R, Balasundaram U. Association of GWAS identified INSR variants (rs2059807 & rs1799817) with polycystic ovarian syndrome in Indian women. Int J Biol Macromol. 2020;144:663\u201370.","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"1091_CR35","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1530\/EJE-08-0932","volume":"160","author":"S Mukherjee","year":"2009","unstructured":"Mukherjee S, Shaikh N, Khavale S, Shinde G, Meherji P, Shah N, et al. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome. Eur J Endocrinol. 2009;160(5):855\u201362.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1091_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ymgme.2009.10.013","volume":"99","author":"A Ioannidis","year":"2010","unstructured":"Ioannidis A, Ikonomi E, Dimou N, Douma L, Bagos P. Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis. Mol Genet Metab. 2010;99(2):174\u201383.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"1091_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1507\/endocrj.EJ11-0387","volume":"59","author":"Y Ruan","year":"2012","unstructured":"Ruan Y, Ma J, Xie X. Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis. Endocr J. 2012;59(7):601\u20139.","journal-title":"Endocr J"},{"key":"1091_CR38","doi-asserted-by":"crossref","unstructured":"Rold\u00e1n B, San Mill\u00e1n J, Escobar-Morreale H. Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy. Am J Pharmacogenomics. 2004;4(2):93\u2013107.","DOI":"10.2165\/00129785-200404020-00004"},{"issue":"5","key":"1091_CR39","doi-asserted-by":"publisher","first-page":"E794","DOI":"10.1152\/ajpendo.00359.2018","volume":"316","author":"M Hu","year":"2019","unstructured":"Hu M, Zhang Y, Guo X, Jia W, Liu G, Zhang J, et al. Hyperandrogenism and insulin resistance induce gravid uterine defects in association with mitochondrial dysfunction and aberrant ROS production. Am J Physiol Endocrinol Metab. 2019;316(5):E794\u2013809.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"1091_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.fertnstert.2013.05.023","volume":"100","author":"D Abbott","year":"2013","unstructured":"Abbott D, Bacha F. Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Fertil Steril. 2013;100(1):2\u201311.","journal-title":"Fertil Steril"},{"issue":"1","key":"1091_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2008.06.020","volume":"297","author":"R Jones","year":"2009","unstructured":"Jones R, Ozanne S. Fetal programming of glucose\u2013insulin metabolism. Mol Cell Endocrinol. 2009;297(1):4\u20139.","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"1091_CR42","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.metabol.2008.02.018","volume":"57","author":"C Pandolfi","year":"2008","unstructured":"Pandolfi C, Zugaro A, Lattanzio F, Necozione S, Barbonetti A, Colangeli M, et al. Low birth weight and later development of insulin resistance and biochemical\/clinical features of polycystic ovary syndrome. Metabolism. 2008;57(7):999\u20131004.","journal-title":"Metabolism"},{"issue":"8","key":"1091_CR43","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1093\/humrep\/deq162","volume":"25","author":"A Melo","year":"2010","unstructured":"Melo A, Vieira C, Barbieri M, Rosa-E-Silva A, Silva A, Cardoso V, et al. High prevalence of polycystic ovary syndrome in women born small for gestational age. Hum Reprod (Oxford, England). 2010;25(8):2124\u201331.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"6865","key":"1091_CR44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"A Saltiel","year":"2001","unstructured":"Saltiel A, Kahn C. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799\u2013806.","journal-title":"Nature"},{"issue":"2 Pt 1","key":"1091_CR45","doi-asserted-by":"publisher","first-page":"C319","DOI":"10.1152\/ajpcell.1994.266.2.C319","volume":"266","author":"JS Lee","year":"1994","unstructured":"Lee JS, Pilch PF. The insulin receptor: Structure, function, and signaling. Am J Physiol. 1994;266(2 Pt 1):C319\u201334.","journal-title":"Am J Physiol"},{"issue":"2","key":"1091_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3904\/kjim.2010.25.2.119","volume":"25","author":"K Choi","year":"2010","unstructured":"Choi K, Kim Y. Molecular mechanism of insulin resistance in obesity and type 2 diabetes. Korean J Intern Med. 2010;25(2):119\u201329.","journal-title":"Korean J Intern Med"},{"key":"1091_CR47","doi-asserted-by":"publisher","first-page":"e923073","DOI":"10.12659\/MSM.923073","volume":"26","author":"J Xu","year":"2020","unstructured":"Xu J, Dun J, Yang J, Zhang J, Lin Q, Huang M, et al. Letrozole rat model mimics human polycystic ovarian syndrome and changes in insulin signal pathways. Med Sci Monit. 2020;26:e923073.","journal-title":"Med Sci Monit"},{"key":"1091_CR48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2019","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2019;502:214\u201321.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"1091_CR49","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1073\/pnas.96.8.4240","volume":"96","author":"LC Cantley","year":"1999","unstructured":"Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase\/AKT pathway. Proc Natl Acad Sci. 1999;96(8):4240\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"1091_CR50","doi-asserted-by":"publisher","first-page":"7781823","DOI":"10.1155\/2021\/7781823","volume":"2021","author":"Z Shaaban","year":"2021","unstructured":"Shaaban Z, Khoradmehr A, Amiri-Yekta A, Nowzari F, JafarzadehShirazi M, Tamadon A. Pathophysiologic mechanisms of insulin secretion and signaling-related genes in etiology of polycystic ovary syndrome. Genetics research. 2021;2021:7781823.","journal-title":"Genetics research"},{"key":"1091_CR51","first-page":"981","volume":"6","author":"DK Evanthia","year":"2012","unstructured":"Evanthia DK, Andrea D. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;6:981\u20131030.","journal-title":"Endocr Rev"},{"issue":"6","key":"1091_CR52","first-page":"2001","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, Aida FDV, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"1091_CR53","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"T Samuel Varman","year":"2012","unstructured":"Samuel Varman T, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148:852\u201371.","journal-title":"Cell"},{"key":"1091_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.697223","volume":"12","author":"S Zhu","year":"2021","unstructured":"Zhu S, Li Z, Hu C, Sun F, Wang C, Yuan H, et al. Imaging-based body fat distribution in polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol. 2021;12: 697223.","journal-title":"Front Endocrinol"},{"issue":"1","key":"1091_CR55","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/s41598-017-17919-5","volume":"8","author":"M Kokosar","year":"2018","unstructured":"Kokosar M, Benrick A, Perfilyev A, Nilsson E, Kllman T, Ohlsson C, et al. A single bout of electroacupuncture remodels epigenetic and transcriptional changes in adipose tissue in polycystic ovary syndrome. Sci Rep. 2018;8(1):1878.","journal-title":"Sci Rep"},{"key":"1091_CR56","doi-asserted-by":"crossref","unstructured":"Polak A, Adamska A, Krentowska A, \u0141ebkowska A, Hryniewicka J, Adamski M, et al. Body composition, serum concentrations of androgens and insulin resistance in different polycystic ovary syndrome phenotypes. J Clin Med. 2020;9(3):732.","DOI":"10.3390\/jcm9030732"},{"key":"1091_CR57","unstructured":"Pasquali R, Gambineri A. The Endocrine Impact of Obesity and Body Habitus in the Polycystic Ovary Syndrome. Humana Press. 2006."},{"issue":"6821","key":"1091_CR58","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/35055575","volume":"409","author":"ED Abel","year":"2001","unstructured":"Abel ED, Peroni O, Kim JK, Kim Y-B, Boss O, Hadro E, et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 2001;409(6821):729\u201333.","journal-title":"Nature"},{"issue":"3","key":"1091_CR59","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1677\/joe.1.07070","volume":"192","author":"A Corbould","year":"2007","unstructured":"Corbould A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol. 2007;192(3):585\u201394.","journal-title":"J Endocrinol"},{"issue":"19","key":"1091_CR60","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.lfs.2007.02.013","volume":"80","author":"M Perello","year":"2007","unstructured":"Perello M, Castrogiovanni D, Giovambattista A, Gaillard R, Spinedi E. Impairment in insulin sensitivity after early androgenization in the post-pubertal female rat. Life Sci. 2007;80(19):1792\u20138.","journal-title":"Life Sci"},{"issue":"7","key":"1091_CR61","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1177\/1933719117746767","volume":"25","author":"M Puttabyatappa","year":"2018","unstructured":"Puttabyatappa M, Lu C, Martin J, Chazenbalk G, Dumesic D, Padmanabhan V. Developmental programming: impact of prenatal testosterone excess on steroidal machinery and cell differentiation markers in visceral adipocytes of female sheep. Reprod Sci (Thousand Oaks, Calif). 2018;25(7):1010\u201323.","journal-title":"Reprod Sci (Thousand Oaks, Calif)"},{"issue":"3","key":"1091_CR62","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00125-003-1324-0","volume":"47","author":"A Dicker","year":"2004","unstructured":"Dicker A, Ryd\u00e9n M, N\u00e4slund E, Muehlen I, Wir\u00e9n M, Lafontan M, et al. Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia. 2004;47(3):420\u20138.","journal-title":"Diabetologia"},{"key":"1091_CR63","first-page":"7","volume":"7","author":"RD Paulukinas","year":"2022","unstructured":"Paulukinas RD, Mesaros CA, Penning TM. Conversion of classical and 11-oxygenated androgens by Insulin-Induced AKR1C3 in a model of human PCOS Adipocytes. Endocrinology. 2022;7:7.","journal-title":"Endocrinology"},{"key":"1091_CR64","doi-asserted-by":"crossref","unstructured":"O\u2019Reilly M, Kempegowda P, Walsh M, Taylor A, Manolopoulos K, Allwood J, et al. AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(9):3327\u201339.","DOI":"10.1210\/jc.2017-00947"},{"issue":"1","key":"1091_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12020-009-9278-8","volume":"37","author":"K Brochu-Gaudreau","year":"2010","unstructured":"Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy B, Palin M. Adiponectin action from head to toe. Endocrine. 2010;37(1):11\u201332.","journal-title":"Endocrine"},{"issue":"5","key":"1091_CR66","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1074\/jbc.M505311200","volume":"281","author":"AR Nawrocki","year":"2006","unstructured":"Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor \u03b3 Agonists. J Biol Chem. 2006;281(5):2654\u201360.","journal-title":"J Biol Chem"},{"issue":"6","key":"1091_CR67","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"E Kershaw","year":"2004","unstructured":"Kershaw E, Flier J. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548\u201356.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1091_CR68","doi-asserted-by":"publisher","first-page":"T47","DOI":"10.1530\/JOE-13-0339","volume":"220","author":"C Haiming","year":"2014","unstructured":"Haiming C. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014;220(2):T47\u201359.","journal-title":"J Endocrinol"},{"issue":"6","key":"1091_CR69","first-page":"375","volume":"15","author":"F Zafari Zangeneh","year":"2017","unstructured":"Zafari Zangeneh F, Naghizadeh M, Masoumi M. Polycystic ovary syndrome and circulating inflammatory markers. Int J Reprod Med. 2017;15(6):375\u201382.","journal-title":"Int J Reprod Med"},{"key":"1091_CR70","doi-asserted-by":"crossref","unstructured":"DeFronzo R. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37(6):667\u201387.","DOI":"10.2337\/diab.37.6.667"},{"issue":"2","key":"1091_CR71","doi-asserted-by":"publisher","first-page":"E392","DOI":"10.1152\/ajpendo.2001.281.2.E392","volume":"281","author":"A Dunaif","year":"2001","unstructured":"Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab. 2001;281(2):E392\u20139.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"1091_CR72","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1210\/jc.2018-00935","volume":"103","author":"E Nilsson","year":"2018","unstructured":"Nilsson E, Benrick A, Kokosar M, Krook A, Lindgren E, K\u00e4llman T, et al. Transcriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2018;103(12):4465\u201377.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1091_CR73","doi-asserted-by":"publisher","first-page":"E1047","DOI":"10.1152\/ajpendo.00361.2004","volume":"288","author":"A Corbould","year":"2005","unstructured":"Corbould A, Kim Y, Youngren J, Pender C, Kahn B, Lee A, et al. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab. 2005;288(5):E1047\u201354.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"1091_CR74","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2337\/diabetes.55.03.06.db05-0453","volume":"55","author":"A Corbould","year":"2006","unstructured":"Corbould A, Zhao H, Mirzoeva S, Aird F, Dunaif A. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes. 2006;55(3):751\u20139.","journal-title":"Diabetes"},{"issue":"2","key":"1091_CR75","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2337\/db07-0706","volume":"57","author":"K H\u00f8jlund","year":"2008","unstructured":"H\u00f8jlund K, Glintborg D, Andersen N, Birk J, Treebak J, Fr\u00f8sig C, et al. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes. 2008;57(2):357\u201366.","journal-title":"Diabetes"},{"issue":"5","key":"1091_CR76","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1210\/jc.2018-01771","volume":"104","author":"S Hansen","year":"2019","unstructured":"Hansen S, Svendsen P, Jeppesen J, Hoeg L, Andersen N, Kristensen J, et al. Molecular mechanisms in skeletal muscle underlying insulin resistance in women who are lean with polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104(5):1841\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1091_CR77","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1042\/BJ20082176","volume":"418","author":"M Rajkhowa","year":"2009","unstructured":"Rajkhowa M, Brett S, Cuthbertson DJ, Lipina C, Ruiz-Alcaraz AJ, Thomas GE, Logie L, Petrie JR, Sutherland C. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1\/2 by insulin in skeletal muscle in vivo. Biochem J. 2009;418(3):665\u201371.","journal-title":"Biochem J"},{"issue":"1","key":"1091_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004274","volume":"4","author":"M Allemand","year":"2009","unstructured":"Allemand M, Irving B, Asmann Y, Klaus K, Tatpati L, Coddington C, et al. Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes\u2013a potential model for PCOS-related insulin resistance. PLoS ONE. 2009;4(1): e4274.","journal-title":"PLoS ONE"},{"issue":"8","key":"1091_CR79","doi-asserted-by":"publisher","first-page":"e13255","DOI":"10.1111\/obr.13255","volume":"22","author":"M Kazemi","year":"2021","unstructured":"Kazemi M, Pierson R, Parry S, Kaviani M, Chilibeck P. Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive-aged women with polycystic ovary syndrome: A systematic review and meta-analysis of 45 observational studies. Obes Rev. 2021;22(8):e13255.","journal-title":"Obes Rev"},{"issue":"5","key":"1091_CR80","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1007\/s00125-011-2442-8","volume":"55","author":"SK Hutchison","year":"2012","unstructured":"Hutchison SK, Teede HJ, Racho\u0144 D, Harrison CL, Strauss BJ, Stepto NK. Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome. Diabetologia. 2012;55(5):1424\u201334.","journal-title":"Diabetologia"},{"issue":"9","key":"1091_CR81","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.2337\/db07-0275","volume":"56","author":"V Skov","year":"2007","unstructured":"Skov V, Glintborg D, Knudsen S, Jensen T, Kruse T, Tan Q, et al. Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome. Diabetes. 2007;56(9):2349\u201355.","journal-title":"Diabetes"},{"issue":"1","key":"1091_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1172\/JCI77812","volume":"126","author":"V Samuel","year":"2016","unstructured":"Samuel V, Shulman G. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Investig. 2016;126(1):12\u201322.","journal-title":"J Clin Investig"},{"issue":"1","key":"1091_CR83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/19396368.2017.1410591","volume":"64","author":"R Deswal","year":"2018","unstructured":"Deswal R, Yadav A, Dang A. Sex hormone binding globulin - an important biomarker for predicting PCOS risk: a systematic review and meta-analysis. Syst Biol Reprod Med. 2018;64(1):12\u201324.","journal-title":"Syst Biol Reprod Med"},{"issue":"1","key":"1091_CR84","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1097-2765(05)00015-8","volume":"6","author":"M Michael","year":"2000","unstructured":"Michael M, Kulkarni R, Postic C, Previs S, Shulman G, Magnuson M, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell. 2000;6(1):87\u201397.","journal-title":"Mol Cell"},{"issue":"10","key":"1091_CR85","doi-asserted-by":"publisher","first-page":"e21921","DOI":"10.1096\/fj.202100961R","volume":"35","author":"S Andrisse","year":"2021","unstructured":"Andrisse S, Feng M, Wang Z, Awe O, Yu L, Zhang H, et al. Androgen-induced insulin resistance is ameliorated by deletion of hepatic androgen receptor in females. FASEB J. 2021;35(10):e21921.","journal-title":"FASEB J"},{"key":"1091_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105829","volume":"208","author":"P Cui","year":"2021","unstructured":"Cui P, Hu W, Ma T, Hu M, Tong X, Zhang F, et al. Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats. J Steroid Biochem Mol Biol. 2021;208: 105829.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"1091_CR87","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/biomedicines10010131","volume":"10","author":"S Spremovi\u0107 Ra\u0111enovi\u0107","year":"2022","unstructured":"Spremovi\u0107 Ra\u0111enovi\u0107 S, Pupovac M, Andji\u0107 M, Bila J, Sre\u0107kovi\u0107 S, Gudovi\u0107 A, et al. Prevalence, risk factors, and pathophysiology of nonalcoholic fatty liver disease (NAFLD) in women with Polycystic Ovary Syndrome (PCOS). Biomedicines. 2022;10(1):131.","journal-title":"Biomedicines"},{"issue":"8","key":"1091_CR88","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/BF03345743","volume":"32","author":"G Targher","year":"2009","unstructured":"Targher G, Solagna E, Tosi F, Castello R, Spiazzi G, Zoppini G, et al. Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. J Endocrinol Invest. 2009;32(8):695\u2013700.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1091_CR89","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/humrep\/dep380","volume":"25","author":"E Vassilatou","year":"2010","unstructured":"Vassilatou E, Lafoyianni S, Vryonidou A, Ioannidis D, Kosma L, Katsoulis K, et al. Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome. Human Reprod (Oxford, England). 2010;25(1):212\u201320.","journal-title":"Human Reprod (Oxford, England)"},{"issue":"7","key":"1091_CR90","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1365-2036.2011.04579.x","volume":"33","author":"A Baranova","year":"2011","unstructured":"Baranova A, Tran T, Birerdinc A, Younossi Z. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;33(7):801\u201314.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1091_CR91","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1017\/S0954422416000287","volume":"30","author":"Y Jeanes","year":"2017","unstructured":"Jeanes Y, Reeves S. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges. Nutr Res Rev. 2017;30(1):97\u2013105.","journal-title":"Nutr Res Rev"},{"key":"1091_CR92","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.lfs.2019.04.046","volume":"228","author":"Y Li","year":"2019","unstructured":"Li Y, Chen C, Ma Y, Xiao J, Luo G, Li Y, et al. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS). Life Sci. 2019;228:167\u201375.","journal-title":"Life Sci"},{"issue":"2","key":"1091_CR93","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0889-8529(05)70074-8","volume":"28","author":"S Franks","year":"1999","unstructured":"Franks S, Gilling-Smith C, Watson H, Willis D. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am. 1999;28(2):361\u201378.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"1091_CR94","doi-asserted-by":"publisher","first-page":"er.2015","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS). Endocrine Reviews. 2016;37(5):er.2015-1104.","journal-title":"Endocrine Reviews"},{"key":"1091_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116940","volume":"236","author":"J Wang","year":"2019","unstructured":"Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236: 116940.","journal-title":"Life Sci"},{"key":"1091_CR96","first-page":"100937","volume":"35","author":"M Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido M, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol\u00a0Metab. 2020;35:100937.","journal-title":"Mol\u00a0Metab"},{"issue":"7","key":"1091_CR97","doi-asserted-by":"publisher","first-page":"9563","DOI":"10.1096\/fj.202000605RR","volume":"34","author":"C Zhang","year":"2020","unstructured":"Zhang C, Hu J, Wang W, Sun Y, Sun K. HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS. FASEB J. 2020;34(7):9563\u201374.","journal-title":"FASEB J"},{"issue":"2","key":"1091_CR98","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/humrep\/deh609","volume":"20","author":"S Rice","year":"2005","unstructured":"Rice S, Christoforidis N, Gadd C, Nikolaou D, Seyani L, Donaldson A, et al. Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries. Human Reprod (Oxford, England). 2005;20(2):373\u201381.","journal-title":"Human Reprod (Oxford, England)"},{"issue":"3","key":"1091_CR99","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","volume":"27","author":"S Palomba","year":"2021","unstructured":"Palomba S, Piltonen T, Giudice L. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2021;27(3):584\u2013618.","journal-title":"Hum Reprod Update"},{"issue":"10","key":"1091_CR100","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s00109-021-02104-z","volume":"99","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Hu M, Yang F, Zhang Y, Ma S, Zhang D, et al. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance. J Mol Med (Berl). 2021;99(10):1427\u201346.","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"1091_CR101","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1530\/REP-13-0135","volume":"146","author":"J Xue","year":"2013","unstructured":"Xue J, Zhang H, Liu W, Liu M, Shi M, Wen Z, et al. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis. Reproduction (Cambridge, England). 2013;146(4):397\u2013406.","journal-title":"Reproduction (Cambridge, England)"},{"key":"1091_CR102","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mce.2005.07.002","volume":"242","author":"H Kim","year":"2005","unstructured":"Kim H, DiVall S, Deneau R, Wolfe A. Insulin regulation of GnRH gene expression through MAP kinase signaling pathways. Mol Cell Endocrinol. 2005;242:42\u20139.","journal-title":"Mol Cell Endocrinol"},{"issue":"5487","key":"1091_CR103","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","volume":"289","author":"JC Br\u00fcning","year":"2000","unstructured":"Br\u00fcning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, et al. Role of brain insulin receptor in control of body weight and reproduction. Science. 2000;289(5487):2122\u20135.","journal-title":"Science"},{"key":"1091_CR104","doi-asserted-by":"crossref","unstructured":"Burks D, Font de Mora J, Schubert M, Withers D, Myers M, Towery H, et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature. 2000;407(6802):377\u201382.","DOI":"10.1038\/35030105"},{"issue":"5","key":"1091_CR105","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1177\/1933719116670265","volume":"24","author":"S-H Zheng","year":"2017","unstructured":"Zheng S-H, Du D-F, Li X-L. Leptin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Reprod Sci. 2017;24(5):656\u201370.","journal-title":"Reprod Sci"},{"issue":"4","key":"1091_CR106","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cmet.2010.03.002","volume":"11","author":"J Hill","year":"2010","unstructured":"Hill J, Elias C, Fukuda M, Williams K, Berglund E, Holland W, et al. Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility. Cell Metab. 2010;11(4):286\u201397.","journal-title":"Cell Metab"},{"issue":"4","key":"1091_CR107","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1210\/endo-108-4-1441","volume":"108","author":"E Adashi","year":"1981","unstructured":"Adashi E, Hsueh A, Yen S. Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology. 1981;108(4):1441\u20139.","journal-title":"Endocrinology"},{"issue":"3","key":"1091_CR108","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.cmet.2010.06.010","volume":"12","author":"K Brothers","year":"2010","unstructured":"Brothers K, Wu S, DiVall S, Messmer M, Kahn C, Miller R, et al. Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor. Cell Metab. 2010;12(3):295\u2013305.","journal-title":"Cell Metab"},{"issue":"1","key":"1091_CR109","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.fertnstert.2006.11.076","volume":"88","author":"D Romualdi","year":"2007","unstructured":"Romualdi D, Giuliani M, Draisci G, Costantini B, Cristello F, Lanzone A, et al. Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome. Fertil Steril. 2007;88(1):131\u20138.","journal-title":"Fertil Steril"},{"issue":"6","key":"1091_CR110","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1210\/endo-127-6-3180","volume":"127","author":"M Sar","year":"1990","unstructured":"Sar M, Lubahn D, French F, Wilson E. Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology. 1990;127(6):3180\u20136.","journal-title":"Endocrinology"},{"issue":"12","key":"1091_CR111","doi-asserted-by":"publisher","first-page":"e98607","DOI":"10.1172\/jci.insight.98607","volume":"3","author":"G Navarro","year":"2018","unstructured":"Navarro G, Allard C, Morford J, Xu W, Liu S, Molinas A, et al. Androgen excess in pancreatic \u03b2 cells and neurons predisposes female mice to type 2 diabetes. JCI Insight. 2018;3(12):e98607.","journal-title":"JCI Insight"},{"issue":"5","key":"1091_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064801","volume":"8","author":"H Shen","year":"2013","unstructured":"Shen H, Qiu L, Zhang Z, Qin Y, Cao C, Di W. Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome. PLoS ONE. 2013;8(5): e64801.","journal-title":"PLoS ONE"},{"issue":"3","key":"1091_CR113","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s12013-013-9602-z","volume":"67","author":"W Ting","year":"2013","unstructured":"Ting W, Yanyan Q, Jian H, Keqin H, Duan M. The relationship between insulin resistance and CpG island methylation of LMNA gene in polycystic ovary syndrome. Cell Biochem Biophys. 2013;67(3):1041\u20137.","journal-title":"Cell Biochem Biophys"},{"key":"1091_CR114","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/bs.acc.2015.06.001","volume":"71","author":"I Ilie","year":"2015","unstructured":"Ilie I, Georgescu C. Polycystic ovary syndrome-epigenetic mechanisms and aberrant MicroRNA. Adv Clin Chem. 2015;71:25\u201345.","journal-title":"Adv Clin Chem"},{"issue":"5","key":"1091_CR115","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1159\/000358698","volume":"33","author":"W Long","year":"2014","unstructured":"Long W, Zhao C, Ji C, Ding H, Cui Y, Guo X, et al. Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers. Cell Physiol Biochem. 2014;33(5):1304\u201315.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"1091_CR116","first-page":"73","volume":"13","author":"F He","year":"2020","unstructured":"He F, Li Y. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J\u00a0Ovarian Res. 2020;13(1):73.","journal-title":"J\u00a0Ovarian Res"},{"issue":"3","key":"1091_CR117","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11154-017-9407-2","volume":"18","author":"G Muscogiuri","year":"2017","unstructured":"Muscogiuri G, Altieri B, de Angelis C, Palomba S, Pivonello R, Colao A, et al. Shedding new light on female fertility: the role of vitamin D. Rev Endocr Metab Disord. 2017;18(3):273\u201383.","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"1091_CR118","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/nu13041178","volume":"13","author":"M Ciebiera","year":"2021","unstructured":"Ciebiera M, Esfandyari S, Siblini H, Prince L, Elkafas H, Wojty\u0142a C, et al. Nutrition in gynecological diseases: current perspectives. Nutrients. 2021;13(4):1178.","journal-title":"Nutrients"},{"key":"1091_CR119","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.trsl.2020.02.003","volume":"219","author":"S Li","year":"2020","unstructured":"Li S, Zhai J, Chu W, Geng X, Chen Z, Du Y. Altered circadian clock as a novel therapeutic target for constant darkness-induced insulin resistance and hyperandrogenism of polycystic ovary syndrome. Transl Res. 2020;219:13\u201329.","journal-title":"Transl Res"},{"issue":"3","key":"1091_CR120","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.pneurobio.2008.04.001","volume":"85","author":"S Pandi-Perumal","year":"2008","unstructured":"Pandi-Perumal S, Trakht I, Srinivasan V, Spence D, Maestroni G, Zisapel N, et al. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol. 2008;85(3):335\u201353.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"1091_CR121","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000323542","volume":"72","author":"C Li","year":"2011","unstructured":"Li C, Shi Y, You L, Wang L, Chen Z. Melatonin receptor 1A gene polymorphism associated with polycystic ovary syndrome. Gynecol Obstet Invest. 2011;72(2):130\u20134.","journal-title":"Gynecol Obstet Invest"},{"issue":"3","key":"1091_CR122","first-page":"2220","volume":"19","author":"X Xu","year":"2019","unstructured":"Xu X, Kou L, Wang H, Bo C, Song X. Genetic polymorphisms of melatonin receptors 1A and 1B may result in disordered lipid metabolism in obese patients with polycystic ovary syndrome. Mol Med Rep. 2019;19(3):2220\u201330.","journal-title":"Mol Med Rep"},{"key":"1091_CR123","doi-asserted-by":"crossref","unstructured":"Yi S, Xu J, Shi H, Li W, Li Q, Sun Y. Association between melatonin receptor gene polymorphisms and polycystic ovarian syndrome: a systematic review and meta-analysis. Biosci Rep. 2020;40(6):BSR20200824.","DOI":"10.1042\/BSR20200824"},{"issue":"3","key":"1091_CR124","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tem.2019.01.005","volume":"30","author":"Z Merhi","year":"2019","unstructured":"Merhi Z, Kandaraki E, Diamanti-Kandarakis E. Implications and future perspectives of AGEs in PCOS pathophysiology. Trends Endocrinol Metab. 2019;30(3):150\u201362.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"1091_CR125","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ando.2013.04.002","volume":"74","author":"P Fenichel","year":"2013","unstructured":"Fenichel P, Chevalier N, Brucker-Davis F. Bisphenol A: an endocrine and metabolic disruptor. Ann Endocrinol. 2013;74(3):211\u201320.","journal-title":"Ann Endocrinol"},{"issue":"11","key":"1091_CR126","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/09513590.2018.1460340","volume":"34","author":"S Yang","year":"2018","unstructured":"Yang S, Yang C, Pei R, Li C, Li X, Huang X, et al. Investigation on the association of occupational stress with risk of polycystic ovary syndrome and mediating effects of HOMA-IR. Gynecol Endocrinol. 2018;34(11):961\u20134.","journal-title":"Gynecol Endocrinol"},{"key":"1091_CR127","doi-asserted-by":"crossref","unstructured":"Steegers-Theunissen R, Wiegel R, Jansen P, Laven J, Sinclair K. Polycystic ovary syndrome: a brain disorder characterized by eating problems originating during puberty and adolescence. Int J Mol Sci. 2020;21(21):8211.","DOI":"10.3390\/ijms21218211"},{"issue":"3","key":"1091_CR128","first-page":"E214","volume":"237","author":"R DeFronzo","year":"1979","unstructured":"DeFronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214\u201323.","journal-title":"Am J Physiol"},{"issue":"6","key":"1091_CR129","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.2337\/db07-9903","volume":"56","author":"RN Bergman","year":"2007","unstructured":"Bergman RN. Orchestration of glucose homeostasis: from a small acorn to the California oak. Diabetes. 2007;56(6):1489\u2013501.","journal-title":"Diabetes"},{"issue":"2","key":"1091_CR130","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4239\/wjd.v11.i2.42","volume":"11","author":"C Amisi","year":"2020","unstructured":"Amisi C, Ciccozzi M, Pozzilli P. Wrist circumference: a new marker for insulin resistance in African women with polycystic ovary syndrome. World J Diabetes. 2020;11(2):42\u201351.","journal-title":"World J Diabetes"},{"issue":"9","key":"1091_CR131","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00125-014-3285-x","volume":"57","author":"J Otten","year":"2014","unstructured":"Otten J, Ahr\u00e9n B, Olsson T. Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Diabetologia. 2014;57(9):1781\u20138.","journal-title":"Diabetologia"},{"key":"1091_CR132","first-page":"173281","volume":"2012","author":"S Xiang","year":"2012","unstructured":"Xiang S, Hua F, Tang Y, Jiang X, Zhuang Q, Qian F. Relationship between serum lipoprotein ratios and insulin resistance in polycystic ovary syndrome. Int\u00a0J\u00a0Endocrinol. 2012;2012:173281.","journal-title":"Int\u00a0J\u00a0Endocrinol"},{"issue":"1","key":"1091_CR133","first-page":"29","volume":"10","author":"A Ghaffarzad","year":"2016","unstructured":"Ghaffarzad A, Amani R, Mehrzad Sadaghiani M, Darabi M, Cheraghian B. Correlation of serum lipoprotein ratios with insulin resistance in infertile women with polycystic ovarian syndrome: a case control study. Int J Fertil Steril. 2016;10(1):29\u201335.","journal-title":"Int J Fertil Steril"},{"key":"1091_CR134","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.773781","volume":"12","author":"H He","year":"2021","unstructured":"He H, Feng J, Zhang S, Wang Y, Li J, Gao J, et al. The Apolipoprotein B\/A1 Ratio is associated with metabolic syndrome components, insulin resistance, androgen hormones, and liver enzymes in women with polycystic ovary syndrome. Front Endocrinol. 2021;12: 773781.","journal-title":"Front Endocrinol"},{"issue":"9","key":"1091_CR135","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1007\/s43032-021-00535-0","volume":"28","author":"F Chen","year":"2021","unstructured":"Chen F, Liao Y, Chen M, Yin H, Chen G, Huang Q, et al. Evaluation of the efficacy of sex hormone-binding globulin in insulin resistance assessment based on HOMA-IR in patients with PCOS. Reprod Sci (Thousand Oaks, Calif). 2021;28(9):2504\u201313.","journal-title":"Reprod Sci (Thousand Oaks, Calif)"},{"issue":"2","key":"1091_CR136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148531","volume":"11","author":"Z Peng","year":"2016","unstructured":"Peng Z, Sun Y, Lv X, Zhang H, Liu C, Dai S. Interleukin-6 levels in women with polycystic ovary syndrome: a systematic review and meta-analysis. PLoS ONE. 2016;11(2): e0148531.","journal-title":"PLoS ONE"},{"key":"1091_CR137","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3389\/fendo.2019.00873","volume":"10","author":"A Adamska","year":"2020","unstructured":"Adamska A, \u0141ebkowska A, Krentowska A, Adamski M, Kowalska I. The association between serum ferritin concentration and visceral adiposity estimated by whole-body DXA scan in women with polycystic ovary syndrome. Front Endocrinol. 2020;10:873.","journal-title":"Front Endocrinol"},{"key":"1091_CR138","first-page":"927805","volume":"2015","author":"N Rizk","year":"2015","unstructured":"Rizk N, Sharif E. Leptin as well as free leptin receptor is associated with polycystic ovary syndrome in young women. Int\u00a0J\u00a0Endocrinol. 2015;2015:927805.","journal-title":"Int\u00a0J\u00a0Endocrinol"},{"issue":"1","key":"1091_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-016-0523-8","volume":"40","author":"K Polak","year":"2017","unstructured":"Polak K, Czyzyk A, Simoncini T, Meczekalski B. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest. 2017;40(1):1\u20138.","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1091_CR140","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4239\/wjd.v13.i3.129","volume":"13","author":"C Amisi","year":"2022","unstructured":"Amisi C. Markers of insulin resistance in Polycystic ovary syndrome women: an update. World J Diabetes. 2022;13(3):129\u201349.","journal-title":"World J Diabetes"},{"issue":"3","key":"1091_CR141","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4239\/wjd.v2.i3.33","volume":"2","author":"M Traub","year":"2011","unstructured":"Traub M. Assessing and treating insulin resistance in women with polycystic ovarian syndrome. World J Diabetes. 2011;2(3):33\u201340.","journal-title":"World J Diabetes"},{"issue":"1","key":"1091_CR142","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/GRF.0000000000000594","volume":"64","author":"J Aly","year":"2021","unstructured":"Aly J, Decherney A. Lifestyle modifications in PCOS. Clin Obstet Gynecol. 2021;64(1):83\u20139.","journal-title":"Clin Obstet Gynecol"},{"key":"1091_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.808898","volume":"13","author":"Y Gu","year":"2022","unstructured":"Gu Y, Zhou G, Zhou F, Wu Q, Ma C, Zhang Y, et al. Life modifications and PCOS: old story but new tales. Front Endocrinol. 2022;13: 808898.","journal-title":"Front Endocrinol"},{"issue":"6","key":"1091_CR144","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3390\/nu13061747","volume":"13","author":"S Afrin","year":"2021","unstructured":"Afrin S, AlAshqar A, El Sabeh M, Miyashita-Ishiwata M, Reschke L, Brennan J, et al. Diet and nutrition in gynecological disorders: a focus on clinical studies. Nutrients. 2021;13(6):1747.","journal-title":"Nutrients"},{"issue":"2","key":"1091_CR145","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/09513590400002300","volume":"19","author":"A Hirschberg","year":"2004","unstructured":"Hirschberg A, Naess\u00e9n S, Stridsberg M, Bystr\u00f6m B, Holtet J. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol Endocrinol. 2004;19(2):79\u201387.","journal-title":"Gynecol Endocrinol"},{"key":"1091_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.735954","volume":"12","author":"Y Shang","year":"2021","unstructured":"Shang Y, Zhou H, He R, Lu W. Dietary modification for reproductive health in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol. 2021;12: 735954.","journal-title":"Front Endocrinol"},{"key":"1091_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.876620","volume":"9","author":"S Mei","year":"2022","unstructured":"Mei S, Ding J, Wang K, Ni Z, Yu J. Mediterranean diet combined with a low-carbohydrate dietary pattern in the treatment of overweight polycystic ovary syndrome patients. Front Nutr. 2022;9: 876620.","journal-title":"Front Nutr"},{"issue":"5","key":"1091_CR148","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"H Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale H. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270\u201384.","journal-title":"Nat Rev Endocrinol"},{"key":"1091_CR149","doi-asserted-by":"crossref","unstructured":"Richards C, Meah V, James P, Rees D, Lord R. HIIT\u2019ing or MISS\u2019ing the optimal management of polycystic ovary syndrome: a systematic review and meta-analysis of high- versus moderate-intensity exercise prescription. Front Physiol. 2021;12: 715881.","DOI":"10.3389\/fphys.2021.715881"},{"issue":"5","key":"1091_CR150","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/humrep\/deac047","volume":"37","author":"R Patten","year":"2022","unstructured":"Patten R, McIlvenna L, Levinger I, Garnham A, Shorakae S, Parker A, et al. High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial. Human Reprod (Oxford, England). 2022;37(5):1018\u201329.","journal-title":"Human Reprod (Oxford, England)"},{"key":"1091_CR151","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3389\/fphys.2020.00606","volume":"11","author":"R Patten","year":"2020","unstructured":"Patten R, Boyle R, Moholdt T, Kiel I, Hopkins W, Harrison C, et al. Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis. Front Physiol. 2020;11:606.","journal-title":"Front Physiol"},{"key":"1091_CR152","first-page":"45","volume":"10","author":"R Fernandez","year":"2018","unstructured":"Fernandez R, Moore V, Van Ryswyk E, Varcoe T, Rodgers R, March W, et al. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nat\u00a0Sci\u00a0Sleep. 2018;10:45\u201364.","journal-title":"Nat\u00a0Sci\u00a0Sleep"},{"key":"1091_CR153","doi-asserted-by":"crossref","unstructured":"Ibrahim Y, Alorabi M, Abdelzaher W, Toni N, Thabet K, Hegazy A, et al. Diacerein ameliorates letrozole-induced polycystic ovarian syndrome in rats. Biomed Pharmacother. 2022;149:112870.","DOI":"10.1016\/j.biopha.2022.112870"},{"issue":"7","key":"1091_CR154","first-page":"418","volume":"10","author":"D Zhu","year":"2022","unstructured":"Zhu D, Chen Y, Huang J, Deng H, Shen X, Lu D, et al. Effects of metformin on pregnancy outcome, metabolic profile, and sex hormone levels in women with polycystic ovary syndrome and their offspring: a systematic review and meta-analysis. Ann\u00a0Transl\u00a0Med. 2022;10(7):418.","journal-title":"Ann\u00a0Transl\u00a0Med"},{"issue":"3","key":"1091_CR155","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cen.13795","volume":"89","author":"H Teede","year":"2018","unstructured":"Teede H, Misso M, Costello M, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol. 2018;89(3):251\u201368.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1091_CR156","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.fertnstert.2019.09.011","volume":"113","author":"Y Li","year":"2020","unstructured":"Li Y, Tan J, Wang Q, Duan C, Hu Y, Huang W. Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril. 2020;113(1):197\u2013204.","journal-title":"Fertil Steril"},{"issue":"8","key":"1091_CR157","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1093\/humrep\/det116","volume":"28","author":"R Carvajal","year":"2013","unstructured":"Carvajal R, Rosas C, Kohan K, Gabler F, Vantman D, Romero C, et al. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients. Human Reprod (Oxford, England). 2013;28(8):2235\u201344.","journal-title":"Human Reprod (Oxford, England)"},{"issue":"11","key":"1091_CR158","doi-asserted-by":"publisher","first-page":"19964","DOI":"10.1002\/jcp.28594","volume":"234","author":"Z Chen","year":"2019","unstructured":"Chen Z, Wei H, Zhao X, Xin X, Peng L, Ning Y, et al. Metformin treatment alleviates polycystic ovary syndrome by decreasing the expression of MMP-2 and MMP-9 via H19\/miR-29b-3p and AKT\/mTOR\/autophagy signaling pathways. J Cell Physiol. 2019;234(11):19964\u201376.","journal-title":"J Cell Physiol"},{"key":"1091_CR159","doi-asserted-by":"crossref","unstructured":"Or\u00f3stica M, Astorga I, Plaza-Parrochia F, Poblete C, Carvajal R, Garc\u00eda V, et al. Metformin treatment regulates the expression of molecules involved in adiponectin and insulin signaling pathways in endometria from women with obesity-associated insulin resistance and PCOS. Int J Mol Sci. 2022;23(7):3922.","DOI":"10.3390\/ijms23073922"},{"key":"1091_CR160","first-page":"CD013505","volume":"12","author":"A Sharpe","year":"2019","unstructured":"Sharpe A, Morley L, Tang T, Norman R, Balen A. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2019;12:CD013505.","journal-title":"Cochrane Database Syst Rev"},{"key":"1091_CR161","doi-asserted-by":"crossref","unstructured":"Pi\u0105tkowska-Chmiel I, Herbet M, Gawro\u0144ska-Grzywacz M, Dudka J. Regulation of neuroinflammatory signaling by PPAR\u03b3 Agonist in mouse model of diabetes. Int J Mol Sci. 2022;23(10):5502.","DOI":"10.3390\/ijms23105502"},{"issue":"4","key":"1091_CR162","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00404-017-4480-z","volume":"296","author":"Y Xu","year":"2017","unstructured":"Xu Y, Wu Y, Huang Q. Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis. Arch Gynecol Obstet. 2017;296(4):661\u201377.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"1091_CR163","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/193229680700100212","volume":"1","author":"CA Steiner","year":"2007","unstructured":"Steiner CA, Janez A, Jensterle M, Reisinger K, Forst T, Pf\u00fctzner A. Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. J Diabetes Sci Technol. 2007;1(2):211\u20137.","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"1091_CR164","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-18-0175","volume":"179","author":"V Salamun","year":"2018","unstructured":"Salamun V, Jensterle M, Janez A, Vrtacnik BE. Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study. Eur J Endocrinol. 2018;179(1):1\u201311.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1091_CR165","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40618-021-01666-6","volume":"45","author":"J Ge","year":"2022","unstructured":"Ge J, Wang D, Song W, Shen S, Ge W. The effectiveness and safety of liraglutide in treating overweight\/obese patients with polycystic ovary syndrome: a meta-analysis. J Endocrinol Invest. 2022;45(2):261\u201373.","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"1091_CR166","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.3390\/ijms23084334","volume":"23","author":"K Bednarz","year":"2022","unstructured":"Bednarz K, Kowalczyk K, Cwynar M, Czapla D, Czarkowski W, Kmita D, et al. The Role of Glp-1 receptor agonists in insulin resistance with concomitant obesity treatment in polycystic ovary syndrome. Int J Mol Sci. 2022;23(8):4334.","journal-title":"Int J Mol Sci"},{"key":"1091_CR167","doi-asserted-by":"crossref","unstructured":"Guo C, Huang T, Chen A, Chen X, Wang L, Shen F, et al. Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages. Braz J Med Biol Res. 2016;49(12):e5826.","DOI":"10.1590\/1414-431x20165826"},{"key":"1091_CR168","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fendo.2019.00155","volume":"10","author":"L Knudsen","year":"2019","unstructured":"Knudsen L, Lau J. The discovery and development of liraglutide and semaglutide. Front Endocrinol. 2019;10:155.","journal-title":"Front Endocrinol"},{"issue":"1","key":"1091_CR169","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1210\/clinem\/dgz028","volume":"105","author":"J Devin","year":"2020","unstructured":"Devin J, Nian H, Celedonio J, Wright P, Brown N. Sitagliptin decreases visceral fat and blood glucose in women with Polycystic Ovarian Syndrome. J Clin Endocrinol Metab. 2020;105(1):136\u201351.","journal-title":"J Clin Endocrinol Metab"},{"key":"1091_CR170","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bcp.2015.09.005","volume":"101","author":"I Dardi","year":"2016","unstructured":"Dardi I, Kouvatsos T, Jabbour S. SGLT2 inhibitors. Biochem Pharmacol. 2016;101:27\u201339.","journal-title":"Biochem Pharmacol"},{"key":"1091_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117090","volume":"240","author":"H Yaribeygi","year":"2020","unstructured":"Yaribeygi H, Sathyapalan T, Maleki M, Jamialahmadi T, Sahebkar A. Molecular mechanisms by which SGLT2 inhibitors can induce insulin sensitivity in diabetic milieu: a mechanistic review. Life Sci. 2020;240: 117090.","journal-title":"Life Sci"},{"issue":"11","key":"1091_CR172","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1111\/dom.14495","volume":"23","author":"S Tan","year":"2021","unstructured":"Tan S, Ignatenko S, Wagner F, Dokras A, Seufert J, Zwanziger D, et al. Licogliflozin versus placebo in women with polycystic ovary syndrome: a randomized, double-blind, phase 2 trial. Diabetes Obes Metab. 2021;23(11):2595\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"1091_CR173","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/dom.14583","volume":"24","author":"M Cai","year":"2022","unstructured":"Cai M, Shao X, Xing F, Zhang Y, Gao X, Zeng Q, et al. Efficacy of canagliflozin versus metformin in women with polycystic ovary syndrome: a randomized, open-label, noninferiority trial. Diabetes Obes Metab. 2022;24(2):312\u201320.","journal-title":"Diabetes Obes Metab"},{"key":"1091_CR174","doi-asserted-by":"crossref","unstructured":"Graff S, Mario F, Ziegelmann P, Spritzer P. Effects of orlistat vs. metformin on weight loss-related clinical variables in women with PCOS: systematic review and meta-analysis. Int J Clin Pract. 2016;70(6):450\u201361.","DOI":"10.1111\/ijcp.12787"},{"issue":"1","key":"1091_CR175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2265.2006.02693.x","volume":"66","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol. 2007;66(1):103\u20139.","journal-title":"Clin Endocrinol"},{"issue":"12","key":"1091_CR176","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1210\/en.2017-00564","volume":"158","author":"C Hutch","year":"2017","unstructured":"Hutch C, Sandoval D. The Role of GLP-1 in the metabolic success of bariatric surgery. Endocrinology. 2017;158(12):4139\u201351.","journal-title":"Endocrinology"},{"issue":"6","key":"1091_CR177","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jacc.2017.12.014","volume":"71","author":"M Pareek","year":"2018","unstructured":"Pareek M, Schauer PR, Kaplan LM, Leiter LA, Rubino F, Bhatt DL. Metabolic surgery: weight loss, diabetes, and beyond. J Am Coll Cardiol. 2018;71(6):670\u201387.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"1091_CR178","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.soard.2018.01.008","volume":"14","author":"C Daigle","year":"2018","unstructured":"Daigle C, Brethauer S, Tu C, Petrick A, Morton J, Schauer P, et al. Which postoperative complications matter most after bariatric surgery? prioritizing quality improvement efforts to improve national outcomes. Surg Obes Relat Dis. 2018;14(5):652\u20137.","journal-title":"Surg Obes Relat Dis"},{"issue":"5","key":"1091_CR179","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/obr.12525","volume":"18","author":"NJ Switzer","year":"2017","unstructured":"Switzer NJ, Marcil G, Prasad S, Debru E, Church N, Mitchell P, et al. Long-term hypovitaminosis D and secondary hyperparathyroidism outcomes of the Roux-en-Y gastric bypass: a systematic review. Obes Rev. 2017;18(5):560\u20136.","journal-title":"Obes Rev"},{"key":"1091_CR180","first-page":"5469409","volume":"2017","author":"G Simi","year":"2017","unstructured":"Simi G, Genazzani A, Obino M, Papini F, Pinelli S, Cela V, et al. Inositol and in vitro fertilization with embryo transfer. Int\u00a0J\u00a0Endocrinol. 2017;2017:5469409.","journal-title":"Int\u00a0J\u00a0Endocrinol"},{"issue":"5","key":"1091_CR181","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/jog.12319","volume":"40","author":"A Genazzani","year":"2014","unstructured":"Genazzani A, Santagni S, Ricchieri F, Campedelli A, Rattighieri E, Chierchia E, et al. Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome. J Obstet Gynaecol Res. 2014;40(5):1353\u201360.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"1091_CR182","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/09513590.2014.964640","volume":"31","author":"Z Kamenov","year":"2015","unstructured":"Kamenov Z, Kolarov G, Gateva A, Carlomagno G, Genazzani A. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecol Endocrinol. 2015;31(2):131\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"1091_CR183","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/ph14060504","volume":"14","author":"R Gambioli","year":"2021","unstructured":"Gambioli R, Forte G, Buzzaccarini G, Unfer V, Lagan\u00e0 A. Myo-Inositol as a key supporter of fertility and physiological gestation. Pharmaceuticals (Basel, Switzerland). 2021;14(6):504.","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"19","key":"1091_CR184","doi-asserted-by":"publisher","first-page":"10575","DOI":"10.3390\/ijms221910575","volume":"22","author":"S Dinicola","year":"2021","unstructured":"Dinicola S, Unfer V, Facchinetti F, Soulage C, Greene N, Bizzarri M, et al. Inositols: from established knowledge to novel approaches. Int J Mol Sci. 2021;22(19):10575.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1091_CR185","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/17425255.2022.2071259","volume":"18","author":"A Lagan\u00e0","year":"2022","unstructured":"Lagan\u00e0 A, Forte G, Bizzarri M, Kamenov Z, Bianco B, Kaya C, et al. Inositols in the ovaries: activities and potential therapeutic applications. Expert Opin Drug Metab Toxicol. 2022;18(2):123\u201333.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"1091_CR186","first-page":"1241","volume":"26","author":"A Lagan\u00e0","year":"2022","unstructured":"Lagan\u00e0 A, Monti N, Fedeli V, Gullo G, Bizzarri M. Does Alpha-lipoic acid improve effects on polycystic ovary syndrome? Eur Rev Med Pharmacol Sci. 2022;26(4):1241\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"1091_CR187","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/nu13051677","volume":"13","author":"M Iervolino","year":"2021","unstructured":"Iervolino M, Lepore E, Forte G, Lagan\u00e0 A, Buzzaccarini G, Unfer V. Natural molecules in the management of Polycystic Ovary Syndrome (PCOS): an analytical review. Nutrients. 2021;13(5):1677.","journal-title":"Nutrients"},{"issue":"9","key":"1091_CR188","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10815-016-0751-z","volume":"33","author":"P \u00d6zcan","year":"2016","unstructured":"\u00d6zcan P, F\u0131\u00e7\u0131c\u0131o\u011flu C, Kizilkale O, Yesiladali M, Tok O, Ozkan F, et al. Can Coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage? J Assist Reprod Genet. 2016;33(9):1223\u201330.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"1091_CR189","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/09513590.2017.1381680","volume":"34","author":"E Rahmani","year":"2018","unstructured":"Rahmani E, Jamilian M, Samimi M, Zarezade Mehrizi M, Aghadavod E, Akbari E, et al. The effects of coenzyme Q10 supplementation on gene expression related to insulin, lipid and inflammation in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2018;34(3):217\u201322.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"1091_CR190","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/cen.13288","volume":"86","author":"M Samimi","year":"2017","unstructured":"Samimi M, Zarezade Mehrizi M, Foroozanfard F, Akbari H, Jamilian M, Ahmadi S, et al. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol. 2017;86(4):560\u20136.","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1091_CR191","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.1038\/s41598-022-09082-3","volume":"12","author":"G Tefagh","year":"2022","unstructured":"Tefagh G, Payab M, Qorbani M, Sharifi F, Sharifi Y, Ebrahimnegad Shirvani M, et al. Effect of vitamin E supplementation on cardiometabolic risk factors, inflammatory and oxidative markers and hormonal functions in PCOS (polycystic ovary syndrome): a systematic review and meta-analysis. Sci Rep. 2022;12(1):5770.","journal-title":"Sci Rep"},{"issue":"2","key":"1091_CR192","first-page":"319","volume":"104","author":"A Izadi","year":"2019","unstructured":"Izadi A, Ebrahimi S, Shirazi S, Taghizadeh S, Parizad M, Farzadi L, et al. Hormonal and metabolic effects of Coenzyme Q10 and\/or Vitamin E in patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2019;104(2):319\u201327.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1091_CR193","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/14647273.2017.1283446","volume":"20","author":"S Ahmadi","year":"2017","unstructured":"Ahmadi S, Jamilian M, Karamali M, Tajabadi-Ebrahimi M, Jafari P, Taghizadeh M, et al. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Hum Fertil (Camb). 2017;20(4):254\u201361.","journal-title":"Hum Fertil (Camb)"},{"key":"1091_CR194","doi-asserted-by":"crossref","unstructured":"Li Y, Tan Y, Xia G, Shuai J. Effects of probiotics, prebiotics, and synbiotics on polycystic ovary syndrome: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2021:1\u201317.","DOI":"10.1080\/10408398.2021.1951155"},{"key":"1091_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.806331","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Xu T, Liu R, Wu G, Gu L, Zhang Y, et al. High-fiber diet or combined with acarbose alleviates heterogeneous phenotypes of polycystic ovary syndrome by regulating gut microbiota. Front Endocrinol. 2021;12: 806331.","journal-title":"Front Endocrinol"},{"issue":"6","key":"1091_CR196","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/cen.13003","volume":"84","author":"M Samimi","year":"2016","unstructured":"Samimi M, Jamilian M, Ebrahimi F, Rahimi M, Tajbakhsh B, Asemi Z. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol. 2016;84(6):851\u20137.","journal-title":"Clin Endocrinol"},{"issue":"19","key":"1091_CR197","doi-asserted-by":"publisher","first-page":"10781","DOI":"10.3390\/ijms221910781","volume":"22","author":"T Petrillo","year":"2021","unstructured":"Petrillo T, Battipaglia C, Virmani M, Genazzani A, Genazzani A. Neuroendocrine effects of carnitines on reproductive impairments. Int J Mol Sci. 2021;22(19):10781.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1091_CR198","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00394-021-02659-0","volume":"61","author":"A Sangouni","year":"2022","unstructured":"Sangouni A, Pakravanfar F, Ghadiri-Anari A, Nadjarzadeh A, Fallahzadeh H, Hosseinzadeh M. The effect of L-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight\/obese women with polycystic ovary syndrome: a randomized clinical trial. Eur J Nutr. 2022;61(3):1199\u2013207.","journal-title":"Eur J Nutr"},{"key":"1091_CR199","doi-asserted-by":"crossref","unstructured":"Tauqir S, Israr M, Rauf B, Malik MO, Shah M. Acetyl-L-Carnitine Ameliorates metabolic and endocrine alterations in women with PCOS: a double-blind randomized clinical trial. Adv Ther. 2021(9).","DOI":"10.1007\/s12325-021-01789-5"},{"key":"1091_CR200","doi-asserted-by":"publisher","first-page":"28089","DOI":"10.1038\/srep28089","volume":"6","author":"Y Wang","year":"2016","unstructured":"Wang Y, Fu X, Xu J, Wang Q, Kuang H. Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome. Sci Rep. 2016;6:28089.","journal-title":"Sci Rep"},{"issue":"11","key":"1091_CR201","volume":"9","author":"F Saleem","year":"2017","unstructured":"Saleem F, Rizvi S. New therapeutic approaches in obesity and metabolic syndrome associated with polycystic ovary syndrome. Cureus. 2017;9(11): e1844.","journal-title":"Cureus"},{"issue":"10","key":"1091_CR202","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.3390\/nu13103665","volume":"13","author":"M Rondanelli","year":"2021","unstructured":"Rondanelli M, Riva A, Petrangolini G, Allegrini P, Giacosa A, Fazia T, et al. Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with Polycystic Ovary Syndrome: a one-group pretest-post-test explanatory study. Nutrients. 2021;13(10):3665.","journal-title":"Nutrients"},{"key":"1091_CR203","unstructured":"Chen Y, Song D, Jin WU, Jing Z, Liu L, Jiang R, et al. Improvement effects of Dendrobium candidum on insulin resistance in MKR mice and MIN6 cells. Journal of Jilin University(Medicine Edition). 2018."},{"key":"1091_CR204","unstructured":"Wei XJ, Chen XH, Weng XG, Wang T, Wang L. Effects of Astragalus Polysaccharides on the Insulin Resistance in Rats. Chinese Journal of Experimental Traditional Medical Formulae. 2011."},{"issue":"9","key":"1091_CR205","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1002\/ptr.6420","volume":"33","author":"J Rahmani","year":"2019","unstructured":"Rahmani J, Manzari N, Thompson J, Clark C, Villanueva G, Varkaneh H, et al. The effect of saffron on weight and lipid profile: a systematic review, meta-analysis, and dose-response of randomized clinical trials. Phytother Res. 2019;33(9):2244\u201355.","journal-title":"Phytother Res"},{"key":"1091_CR206","doi-asserted-by":"crossref","unstructured":"Rahimi G, Shams S, Aslani M. Effects of crocin supplementation on inflammatory markers, lipid profiles, insulin and cardioprotective indices in women with PCOS: a randomized, double-blind, placebo-controlled trial. Phytotherapy research\u202f: PTR. 2022;36(6):2605\u201315.","DOI":"10.1002\/ptr.7474"},{"key":"1091_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115057","volume":"289","author":"Y Wu","year":"2022","unstructured":"Wu Y, Li S, Zhu H, Zhuang Z, Shao M, Chen F, et al. Network pharmacology integrated with experimental validation reveals the regulatory mechanism of action of Hehuan Yin decoction in polycystic ovary syndrome with insulin resistance. J Ethnopharmacol. 2022;289: 115057.","journal-title":"J Ethnopharmacol"},{"key":"1091_CR208","doi-asserted-by":"crossref","unstructured":"Raja-Khan N, Stener-Victorin E, Wu X, Legro R. The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. Am J Physiol Endocrinol Metab. 2011;301(1):E1\u201310.","DOI":"10.1152\/ajpendo.00667.2010"},{"key":"1091_CR209","doi-asserted-by":"publisher","first-page":"5555315","DOI":"10.1155\/2021\/5555315","volume":"2021","author":"L Jia","year":"2021","unstructured":"Jia L, Feng J, Li J, Liu F, Xie L, Luo S, et al. The complementary and alternative medicine for polycystic ovary syndrome: a review of clinical application and mechanism. Evid Based Complement Alternat Med. 2021;2021:5555315.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"8","key":"1091_CR210","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1096\/fj.201601381R","volume":"31","author":"A Benrick","year":"2017","unstructured":"Benrick A, Kokosar M, Hu M, Larsson M, Maliqueo M, Marcondes R, et al. Autonomic nervous system activation mediates the increase in whole-body glucose uptake in response to electroacupuncture. FASEB J. 2017;31(8):3288\u201397.","journal-title":"FASEB J"},{"key":"1091_CR211","doi-asserted-by":"publisher","first-page":"5555028","DOI":"10.1155\/2021\/5555028","volume":"2021","author":"R Zheng","year":"2021","unstructured":"Zheng R, Qing P, Han M, Song J, Hu M, Ma H, et al. The effect of acupuncture on glucose metabolism and lipid profiles in patients with PCOS: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2021;2021:5555028.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"1091_CR212","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/humrep\/deab272","volume":"37","author":"Q Wen","year":"2022","unstructured":"Wen Q, Hu M, Lai M, Li J, Hu Z, Quan K, et al. Effect of acupuncture and metformin on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance: a three-armed randomized controlled trial. Human Reprod (Oxford, England). 2022;37(3):542\u201352.","journal-title":"Human Reprod (Oxford, England)"},{"key":"1091_CR213","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.metabol.2018.11.002","volume":"92","author":"C Glueck","year":"2019","unstructured":"Glueck C, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism. 2019;92:108\u201320.","journal-title":"Metabolism"},{"issue":"9","key":"1091_CR214","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1210\/clinem\/dgaa337","volume":"105","author":"C Xing","year":"2020","unstructured":"Xing C, Li C, He B. Insulin sensitizers for improving the endocrine and metabolic profile in overweight women with PCOS. J Clin Endocrinol Metab. 2020;105(9):2950\u201363.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1091_CR215","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12978-021-01207-7","volume":"18","author":"H Zhao","year":"2021","unstructured":"Zhao H, Xing C, Zhang J, He B. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Reprod Health. 2021;18(1):171.","journal-title":"Reprod Health"},{"key":"1091_CR216","doi-asserted-by":"crossref","unstructured":"M\u00fcller TD, Finan B, Bloom SR, D\u2019Alessio D, Drucker DJ, Flatt PR, et al. Glucagon-like peptide 1 (GLP-1). Molecular Metabolism. 2019;30:72\u2013130.","DOI":"10.1016\/j.molmet.2019.09.010"},{"issue":"9","key":"1091_CR217","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1007\/s00125-012-2592-3","volume":"55","author":"Y-S Lee","year":"2012","unstructured":"Lee Y-S, Park M-S, Choung J-S, Kim S-S, Oh H-H, Choi C-S, et al. Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia. 2012;55(9):2456\u201368.","journal-title":"Diabetologia"},{"issue":"9","key":"1091_CR218","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/17512433.2021.1933433","volume":"14","author":"M Siamashvili","year":"2021","unstructured":"Siamashvili M, Davis S. Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. Expert Rev Clin Pharmacol. 2021;14(9):1081\u20139.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"1","key":"1091_CR219","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrneph.2016.170","volume":"13","author":"R DeFronzo","year":"2017","unstructured":"DeFronzo R, Norton L, Abdul-Ghani M. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition. Nat Rev Nephrol. 2017;13(1):11\u201326.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"1091_CR220","doi-asserted-by":"publisher","first-page":"932","DOI":"10.4239\/wjd.v12.i7.932","volume":"12","author":"J Marinkovic-Radosevic","year":"2021","unstructured":"Marinkovic-Radosevic J, Cigrovski Berkovic M, Kruezi E, Bilic-Curcic I, Mrzljak A. Exploring new treatment options for polycystic ovary syndrome: review of a novel antidiabetic agent SGLT2 inhibitor. World J Diabetes. 2021;12(7):932\u20138.","journal-title":"World J Diabetes"},{"issue":"2","key":"1091_CR221","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/0974-8490.94736","volume":"4","author":"L Nampoothiri","year":"2012","unstructured":"Nampoothiri L, Desai B, Maharjan R. Aloe barbadensis Mill. formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model. Pharmacognosy Res. 2012;4(2):109\u201315.","journal-title":"Pharmacognosy Res"},{"key":"1091_CR222","doi-asserted-by":"crossref","unstructured":"Dey A, Dhadhal S, Maharjan R, Nagar PS, Nampoothiri L. Partially purified non-polar phytocomponents from Aloe barbadensis Mill. gel restores metabolic and reproductive comorbidities in letrozole-induced polycystic ovary syndrome rodent model- an \u201cin-vivo\u201d study. Journal of Ethnopharmacology. 2022;291:115161.","DOI":"10.1016\/j.jep.2022.115161"},{"key":"1091_CR223","doi-asserted-by":"crossref","unstructured":"Lin Y, Xiang L, Li X, Tang Q, Meng F, Chen W. Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology. Curr Med Chem. 2022.","DOI":"10.2174\/0929867329666220508180611"},{"issue":"9","key":"1091_CR224","first-page":"10694","volume":"13","author":"C Shao","year":"2021","unstructured":"Shao C, Dong W, Zhang H. Application of Guijiaosan Shenque acupoint paste can improve the scores of obesity, endocrine and TCM symptoms in treating obese polycystic ovary syndrome. Am\u00a0J\u00a0Transl\u00a0Res. 2021;13(9):10694\u2013702.","journal-title":"Am\u00a0J\u00a0Transl\u00a0Res"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-01091-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-022-01091-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-01091-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T07:11:58Z","timestamp":1701673918000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-022-01091-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,11]]},"references-count":224,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1186\/s13048-022-01091-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,11]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}